EU Reached an Agreement for 300 Million Doses of Vaccine

EU Reached an Agreement for 300 Million Doses of Vaccine The EU has reached an agreement for 300 million doses of vaccine. The association signed contracts with companies for the vaccine developed by BioNTech and Pfizer. The European Union (EU) has reached an agreement with companies to purchase 300 million vaccines if the Coronavirus (Covid-19) vaccine developed by BioNTech and Pfizer is safe. Companies hope that vaccines will begin to be delivered by the end of 2020. Alongside this development, the EU has yet to reach an agreement on how these doses will be distributed and to which group the vaccine priority will be given. The Union stated that the work continues in order to reach a decision on this issue. The two companies that develop the vaccine reported on Monday that the vaccine provided 90 percent protection against Coronavirus in the first trials. While the vaccine, which has been tested on 43,500 people, has not yet been found to be harmful, the companies said they plan to make an 'emergency application' at the end of November for the vaccine to be available.   Vaccination can be given after proven safety Emphasizing that the contract signed by the EU is "extremely important", Stella Kyriakides, member of the European Commission responsible for health, said: “This agreement brings us one step closer to our goal of having a large vaccine portfolio. This vaccine will only be introduced after it has been proven safe.” Stating that it is not yet known when the vaccine will be distributed and that this depends on the approval of the European Medicines Agency, Kyriakides used the following statements: “The vaccine does not contain a magic formula that will destroy the virus overnight. If I think optimistically, I can say that the vaccine will start in the first quarter of next year, but it is not possible to speak more clearly.”